Table of Content - Neurodiagnostics Market Trends, Size, Share, Industry Demand, Global Analysis, 2032 | MRFR

Neurodiagnostics Market Segmentation

Neurodiagnostics Product Type Outlook (USD Billion, 2019-2030)

Diagnostic Imaging Systems

Clinical Diagnostic Instruments

Reagents and Consumables

Neurodiagnostics Condition Outlook (USD Billion, 2019-2030)

Neurodegenerative Diseases

Stroke

Epilepsy

Headache Disorders

Sleep Disorders

Others

Neurodiagnostics End User Outlook (USD Billion, 2019-2030)

Hospitals and Surgical Centers

Diagnostic Laboratories and Imaging Centers

Neurology Centers

Ambulatory Care Centers

Research Laboratories and Academic Institutes

Neurodiagnostics Regional Outlook (USD Billion, 2019-2030)

North America Outlook (USD Billion, 2019-2030)
- North America Neurodiagnostics by Product Type
  - Diagnostic Imaging Systems
  - Clinical Diagnostic Instruments
  - Reagents and Consumables
- North America Neurodiagnostics by Condition
  - Neurodegenerative Diseases
  - Stroke
  - Epilepsy
  - Headache Disorders
  - Sleep Disorders
  - Others
- North America Neurodiagnostics by End User
  - Hospitals and Surgical Centers
  - Diagnostic Laboratories and Imaging Centers
  - Neurology Centers
  - Ambulatory Care Centers
  - Research Laboratories and Academic Institutes
- US Outlook (USD Billion, 2019-2030)
- US Neurodiagnostics by Product Type
  - Diagnostic Imaging Systems
  - Clinical Diagnostic Instruments
  - Reagents and Consumables
- US Neurodiagnostics by Condition
  - Neurodegenerative Diseases
  - Stroke
  - Epilepsy
  - Headache Disorders
  - Sleep Disorders
  - Others
- US Neurodiagnostics by End User
  - Hospitals and Surgical Centers
  - Diagnostic Laboratories and Imaging Centers
  - Neurology Centers
  - Ambulatory Care Centers
  - Research Laboratories and Academic Institutes
- CANADA Outlook (USD Billion, 2019-2030)
- Canada Neurodiagnostics by Product Type
  - Diagnostic Imaging Systems
  - Clinical Diagnostic Instruments
  - Reagents and Consumables
- Canada Neurodiagnostics by Condition
  - Neurodegenerative Diseases
  - Stroke
  - Epilepsy
  - Headache Disorders
  - Sleep Disorders
  - Others
- Canada Neurodiagnostics by End User
  - Hospitals and Surgical Centers
  - Diagnostic Laboratories and Imaging Centers
  - Neurology Centers
  - Ambulatory Care Centers
  - Research Laboratories and Academic Institutes

Europe Outlook (USD Billion, 2019-2030)
- Europe Neurodiagnostics by Product Type
  - Diagnostic Imaging Systems
  - Clinical Diagnostic Instruments
  - Reagents and Consumables
- Europe Neurodiagnostics by Condition
  - Neurodegenerative Diseases
  - Stroke
  - Epilepsy
  - Headache Disorders
  - Sleep Disorders
  - Others
- Europe Neurodiagnostics by End User
  - Hospitals and Surgical Centers
  - Diagnostic Laboratories and Imaging Centers
  - Neurology Centers
  - Ambulatory Care Centers
  - Research Laboratories and Academic Institutes
- Germany Outlook (USD Billion, 2019-2030)
- Germany Neurodiagnostics by Product Type
  - Diagnostic Imaging Systems
  - Clinical Diagnostic Instruments
  - Reagents and Consumables
- Germany Neurodiagnostics by Condition
  - Neurodegenerative Diseases
  - Stroke
  - Epilepsy
  - Headache Disorders
  - Sleep Disorders
  - Others
- Germany Neurodiagnostics by End User
  - Hospitals and Surgical Centers
  - Diagnostic Laboratories and Imaging Centers
  - Neurology Centers
  - Ambulatory Care Centers
  - Research Laboratories and Academic Institutes
- France Outlook (USD Billion, 2019-2030)
- France Neurodiagnostics by Product Type
  - Diagnostic Imaging Systems
  - Clinical Diagnostic Instruments
  - Reagents and Consumables
- France Neurodiagnostics by Condition
  - Neurodegenerative Diseases
  - Stroke
  - Epilepsy
  - Headache Disorders
  - Sleep Disorders
  - Others
- France Neurodiagnostics by End User
  - Hospitals and Surgical Centers
  - Diagnostic Laboratories and Imaging Centers
  - Neurology Centers
  - Ambulatory Care Centers
  - Research Laboratories and Academic Institutes
- UK Outlook (USD Billion, 2019-2030)
- UK Neurodiagnostics by Product Type
  - Diagnostic Imaging Systems
  - Clinical Diagnostic Instruments
  - Reagents and Consumables
- UK Neurodiagnostics by Condition
  - Neurodegenerative Diseases
  - Stroke
  - Epilepsy
  - Headache Disorders
  - Sleep Disorders
  - Others
- UK Neurodiagnostics by End User
  - Hospitals and Surgical Centers
  - Diagnostic Laboratories and Imaging Centers
  - Neurology Centers
  - Ambulatory Care Centers
  - Research Laboratories and Academic Institutes
- ITALY Outlook (USD Billion, 2019-2030)
- Italy Neurodiagnostics by Product Type
  - Diagnostic Imaging Systems
  - Clinical Diagnostic Instruments
  - Reagents and Consumables
- Italy Neurodiagnostics by Condition
  - Neurodegenerative Diseases
  - Stroke
  - Epilepsy
  - Headache Disorders
  - Sleep Disorders
  - Others
- Italy Neurodiagnostics by End User
  - Hospitals and Surgical Centers
  - Diagnostic Laboratories and Imaging Centers
  - Neurology Centers
  - Ambulatory Care Centers
  - Research Laboratories and Academic Institutes
- SPAIN Outlook (USD Billion, 2019-2030)
- Spain Neurodiagnostics by Product Type
  - Diagnostic Imaging Systems
  - Clinical Diagnostic Instruments
  - Reagents and Consumables
- Spain Neurodiagnostics by Condition
  - Neurodegenerative Diseases
  - Stroke
  - Epilepsy
  - Headache Disorders
  - Sleep Disorders
  - Others
- Spain Neurodiagnostics by End User
  - Hospitals and Surgical Centers
  - Diagnostic Laboratories and Imaging Centers
  - Neurology Centers
  - Ambulatory Care Centers
  - Research Laboratories and Academic Institutes
- Rest Of Europe Outlook (USD Billion, 2019-2030)
- Rest of Europe Neurodiagnostics by Product Type
  - Diagnostic Imaging Systems
  - Clinical Diagnostic Instruments
  - Reagents and Consumables
- Rest of Europe Neurodiagnostics by Condition
  - Neurodegenerative Diseases
  - Stroke
  - Epilepsy
  - Headache Disorders
  - Sleep Disorders
  - Others
- Rest of Europe Neurodiagnostics by End User
  - Hospitals and Surgical Centers
  - Diagnostic Laboratories and Imaging Centers
  - Neurology Centers
  - Ambulatory Care Centers
  - Research Laboratories and Academic Institutes

Asia-Pacific Outlook (USD Billion, 2019-2030)
- Asia-Pacific Neurodiagnostics by Product Type
  - Diagnostic Imaging Systems
  - Clinical Diagnostic Instruments
  - Reagents and Consumables
- Asia-Pacific Neurodiagnostics by Condition
  - Neurodegenerative Diseases
  - Stroke
  - Epilepsy
  - Headache Disorders
  - Sleep Disorders
  - Others
- Asia-Pacific Neurodiagnostics by End User
  - Hospitals and Surgical Centers
  - Diagnostic Laboratories and Imaging Centers
  - Neurology Centers
  - Ambulatory Care Centers
  - Research Laboratories and Academic Institutes
- China Outlook (USD Billion, 2019-2030)
- China Neurodiagnostics by Product Type
  - Diagnostic Imaging Systems
  - Clinical Diagnostic Instruments
  - Reagents and Consumables
- China Neurodiagnostics by Condition
  - Neurodegenerative Diseases
  - Stroke
  - Epilepsy
  - Headache Disorders
  - Sleep Disorders
  - Others
- China Neurodiagnostics by End User
  - Hospitals and Surgical Centers
  - Diagnostic Laboratories and Imaging Centers
  - Neurology Centers
  - Ambulatory Care Centers
  - Research Laboratories and Academic Institutes
- Japan Outlook (USD Billion, 2019-2030)
- Japan Neurodiagnostics by Product Type
  - Diagnostic Imaging Systems
  - Clinical Diagnostic Instruments
  - Reagents and Consumables
- Japan Neurodiagnostics by Condition
  - Neurodegenerative Diseases
  - Stroke
  - Epilepsy
  - Headache Disorders
  - Sleep Disorders
  - Others
- Japan Neurodiagnostics by End User
  - Hospitals and Surgical Centers
  - Diagnostic Laboratories and Imaging Centers
  - Neurology Centers
  - Ambulatory Care Centers
  - Research Laboratories and Academic Institutes
- India Outlook (USD Billion, 2019-2030)
- India Neurodiagnostics by Product Type
  - Diagnostic Imaging Systems
  - Clinical Diagnostic Instruments
  - Reagents and Consumables
- India Neurodiagnostics by Condition
  - Neurodegenerative Diseases
  - Stroke
  - Epilepsy
  - Headache Disorders
  - Sleep Disorders
  - Others
- India Neurodiagnostics by End User
  - Hospitals and Surgical Centers
  - Diagnostic Laboratories and Imaging Centers
  - Neurology Centers
  - Ambulatory Care Centers
  - Research Laboratories and Academic Institutes
- Australia Outlook (USD Billion, 2019-2030)
- Australia Neurodiagnostics by Product Type
  - Diagnostic Imaging Systems
  - Clinical Diagnostic Instruments
  - Reagents and Consumables
- Australia Neurodiagnostics by Condition
  - Neurodegenerative Diseases
  - Stroke
  - Epilepsy
  - Headache Disorders
  - Sleep Disorders
  - Others
- Australia Neurodiagnostics by End User
  - Hospitals and Surgical Centers
  - Diagnostic Laboratories and Imaging Centers
  - Neurology Centers
  - Ambulatory Care Centers
  - Research Laboratories and Academic Institutes
- Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)
- Rest of Asia-Pacific Neurodiagnostics by Product Type
  - Diagnostic Imaging Systems
  - Clinical Diagnostic Instruments
  - Reagents and Consumables
- Rest of Asia-Pacific Neurodiagnostics by Condition
  - Neurodegenerative Diseases
  - Stroke
  - Epilepsy
  - Headache Disorders
  - Sleep Disorders
  - Others
- Rest of Asia-Pacific Neurodiagnostics by End User
  - Hospitals and Surgical Centers
  - Diagnostic Laboratories and Imaging Centers
  - Neurology Centers
  - Ambulatory Care Centers
  - Research Laboratories and Academic Institutes

Rest of the World Outlook (USD Billion, 2019-2030)
- Rest of the World Neurodiagnostics by Product Type
  - Diagnostic Imaging Systems
  - Clinical Diagnostic Instruments
  - Reagents and Consumables
- Rest of the World Neurodiagnostics by Condition
  - Neurodegenerative Diseases
  - Stroke
  - Epilepsy
  - Headache Disorders
  - Sleep Disorders
  - Others
- Rest of the World Neurodiagnostics by End User
  - Hospitals and Surgical Centers
  - Diagnostic Laboratories and Imaging Centers
  - Neurology Centers
  - Ambulatory Care Centers
  - Research Laboratories and Academic Institutes
- Middle East Outlook (USD Billion, 2019-2030)
- Middle East Neurodiagnostics by Product Type
  - Diagnostic Imaging Systems
  - Clinical Diagnostic Instruments
  - Reagents and Consumables
- Middle East Neurodiagnostics by Condition
  - Neurodegenerative Diseases
  - Stroke
  - Epilepsy
  - Headache Disorders
  - Sleep Disorders
  - Others
- Middle East Neurodiagnostics by End User
  - Hospitals and Surgical Centers
  - Diagnostic Laboratories and Imaging Centers
  - Neurology Centers
  - Ambulatory Care Centers
  - Research Laboratories and Academic Institutes
- Africa Outlook (USD Billion, 2019-2030)
- Africa Neurodiagnostics by Product Type
  - Diagnostic Imaging Systems
  - Clinical Diagnostic Instruments
  - Reagents and Consumables
- Africa Neurodiagnostics by Condition
  - Neurodegenerative Diseases
  - Stroke
  - Epilepsy
  - Headache Disorders
  - Sleep Disorders
  - Others
- Africa Neurodiagnostics by End User
  - Hospitals and Surgical Centers
  - Diagnostic Laboratories and Imaging Centers
  - Neurology Centers
  - Ambulatory Care Centers
  - Research Laboratories and Academic Institutes
- Latin America Outlook (USD Billion, 2019-2030)
- Latin America Neurodiagnostics by Product Type
  - Diagnostic Imaging Systems
  - Clinical Diagnostic Instruments
  - Reagents and Consumables
- Latin America Neurodiagnostics by Condition
  - Neurodegenerative Diseases
  - Stroke
  - Epilepsy
  - Headache Disorders
  - Sleep Disorders
  - Others
- Latin America Neurodiagnostics by End User
  - Hospitals and Surgical Centers
  - Diagnostic Laboratories and Imaging Centers
  - Neurology Centers
  - Ambulatory Care Centers
  - Research Laboratories and Academic Institutes

Research Methodology on Neurodiagnostics Market

1. Introduction

This research study endeavours to analyze the neurodiagnostics market in terms of market size, revenue, growth rate, and potential opportunities. While the scope of this study briefly encompasses the market’s historical trajectory and its projected forecast from 2023 to 2030, the Neurology Diagnostics market report additionally identifies and examines emerging trends, strategies, and business models at the industry level.

2. Research Approach

In order to thoroughly assess the Neurodiagnostics Market, Market Research Future (MRFR) formulated data-driven insights through an in-depth interpretation of primary and secondary information sources. To obtain detailed information regarding the market, MRFR's analysts conducted interviews with key personnel and representatives from industry-leading companies, research reports, and trade journals.

Using qualitative and quantitative methods, the analysts conducted an independent industry assessment to gain an accurate approximation of the market’s size and potential. Additionally, the research process is expedited by framing a comprehensive questionnaire collecting pertinent information regarding the neurodiagnostics market’s growth and regional coverage.

3. Data Accuracy

The primary sources of the neurodiagnostics market data and analysis include interviews with industry-leading experts and executives, as well as ubiquitous trade journals, magazines, and articles. The secondary data sourcing from leading organizations is used to update and verify the collected information. All data used in the report is collected from several reliable sources, including white papers, corporate climate reports, company websites, and reports from renowned and trustworthy agencies and organizations such as the American Academy of Neurology, European Society of Neurology, American Association of Neurosciences, and American College of Clinical Neurophysiology.

4. Data Collection and Estimation:

The data collected from secondary and primary sources are used to analyze the market through in-depth interviews with industry-leading professionals. The information obtained from the qualitative and quantitative analysis of the primary and secondary sources is grouped into various segments and subsegments.

5. Forecasting Model

To evaluate current and future market developments, market estimations have been calculated based on a combination of economic, statistical, and financial modelling techniques. The methodology used is both top-down and bottom-up approaches. All statistical and numeric data derived from primary and secondary research is used to conduct various tests including the Demand & Supply Side Trend Analysis, Porter’s Five Forces model, Markov analysis, PESTEL analysis, and SWOT Analysis.

6. Variables/Factors Influencing the Market

The Neurodiagnostics market is affected by changing dynamics in the global healthcare market, such as technological advancements, the introduction of novel products, changes in market structure, and others. Additionally, certain external and internal factors have further impacted the global market, such as the launch of new products and services, massive investments in research and development activities, growing demand for healthcare services, legal and regulatory complexities, and the inclusion of competitive strategies in the global market.

7. Conclusion

To summarize, the neurodiagnostics market is anticipated to grow considerably, mainly driven by increasing R&D investments, a growing patient population, and technological developments. However, the growth of the market is subject to certain sociocultural, legal, political, and economic factors. The report’s in-depth market research provides an accurate assessment of the neurodiagnostics market conditions and helps to draw a meaningful inference. The report thus presents the true market picture and sorted out the various market dynamics, affecting the neurodiagnostics market. The report also helps to identify future market opportunities and assess the risk associated with them along with the forecast from 2023 to 2030.

Leading companies partner with us for data-driven Insights

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

3.5. Forecast Model

3.6. List of Assumptions

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

6. GLOBAL WHOLE EXOME SEQUENCING MARKET, BY PRODUCT

6.1. Overview

6.2. Sequencer